adenosine monophosphate has been researched along with Dermatitis Medicamentosa in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bickel, C; Heck, J; Jöckel, J; Krichevsky, B; Mettin, R; Stichtenoth, DO | 1 |
| Grundmark, B; Vidlin, SH; Watson, S; Zekarias, A | 1 |
| Goldust, M; Sandhu, S; Schwartz, RA; Sharma, A; Szepietowski, JC | 1 |
| Dellavalle, RP; Presley, CL; Pulsipher, KJ; Szeto, MD; Waller, JD | 1 |
2 review(s) available for adenosine monophosphate and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Remdesivir-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE)? A case report with review of the literature.
Topics: Adenosine Monophosphate; Aged; Alanine; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Drug Eruptions; Exanthema; Humans; Male | 2021 |
Systemic Medications of Dermatological Importance in COVID-19.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Biological Products; Coronavirus Infections; COVID-19; Dermatologic Agents; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Pandemics; Pneumonia, Viral; Prognosis; Risk Assessment; Severe Acute Respiratory Syndrome | 2020 |
2 other study(ies) available for adenosine monophosphate and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
Topics: Abdominal Pain; Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azithromycin; Chemical and Drug Induced Liver Injury; Chloroquine; COVID-19 Drug Treatment; Databases, Pharmaceutical; Diarrhea; Drug Combinations; Drug Eruptions; Drug Repositioning; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxychloroquine; Long QT Syndrome; Lopinavir; Male; Nausea; Oseltamivir; Ritonavir; Sex Distribution; Sex Factors; Vomiting | 2020 |
Remdesivir Use in COVID-19 Patients: Cutaneous Adverse Effect or Disease Manifestation?
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Diagnosis, Differential; Drug Eruptions; Humans | 2021 |